Q2 2025 Earnings Call Transcript August 19, 2025 Operator: Hello, and welcome to Evaxion’s Second Quarter 2025 Conference Call. [Operator Instructions] I would now like to turn the conference over to ...

MSD rates in Louisville won't be going up as much as expected this year.The utility announced in May that the board of directors had approved a 4.9% increase for Jefferson County that was set to ...

MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured cancer drug Keytruda, the best-selling medicine in the world.

MSD expects to see an additional $200m layered onto its costs this year as a result of President Trump's tariffs, ahead of any pharma-specific levy.

Armed with positive results in two phase 3 trials, MSD is poised to be the first to file for approval of an oral PCSK9 drug to lower cholesterol ...

While UTRA-enhanced adherence support improved long-term ART exposure and reduced inflammation, it did not result in significantly higher virologic suppression.

If approved, Signatera could help physicians to monitor molecular markers of bladder cancer relapse, allowing them to ...

Biochemical assays articles from across Nature Portfolio A biochemical assay is an analytical in vitro procedure used to detect, quantify and/or study the binding or activity of a biological ...

The firm's goal for its SeekIt platform is to combine the accessibility of antibody and antigen testing and the accuracy of PCR for use in low-resource settings.

The MMR IHC Panel PharmaDx (Dako Omnis) is used to identify loss of function in mismatch repair proteins and inform the treatment of colorectal cancer patients.

Researchers at three Boston institutions are advancing a ctDNA assay with the goal of getting more children with solid tumors into biomarker-directed therapies and trials.